TRIM21 Expression as a Prognostic Biomarker for Progression-Free Survival in HNSCC

TRIM21 Expression as a Prognostic Biomarker for Progression-Free Survival in HNSCC

Patients with head and neck squamous cell carcinoma (HNSCC) continue to have a rather poor prognosis. Treatment-related comorbidities have negative impacts on their quality of life. TRIM21 is a cytosolic E3 ubiquitin ligase that was initially described as an autoantigen in autoimmune diseases and la...

Full description

Bibliographic Details
Main Authors: Amelie von Bernuth, Julika Ribbat-Idel, Luise Klapper, Tobias Jagomast, Dirk Rades, Anke Leichtle, Ralph Pries, Karl-Ludwig Bruchhage, Sven Perner, Anne Offermann, Verena Sailer, Christian Idel
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:International Journal of Molecular Sciences
Subjects:
TRIM21
head and neck squamous cell carcinoma (HNSCC)
prognostic biomarker
immune cell infiltration
IHC
Online Access:https://www.mdpi.com/1422-0067/24/6/5140

Internet

https://www.mdpi.com/1422-0067/24/6/5140

Similar Items